ACIU AC Immune Ltd

USD 1.64 -0.02 ( -1.20%)
Icon

AC Immune Ltd (ACIU) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.64

-0.02 (-1.20%)

USD 0.21B

0.11M

USD 16.00(+875.61%)

USD 10.00 (+509.76%)

Icon

ACIU

AC Immune Ltd (USD)
COMMON STOCK | NSD
USD 1.64
-0.02 ( -1.20%)

AC Immune Ltd (ACIU) Annual Income Statement (USD)

ACIU Quarterly Financials (USD)

Frequently Asked Questions About AC Immune Ltd (ACIU) Stock

AC Immune Ltd's (ACIU) last reported annual revenue was USD 27.31 Million.

AC Immune Ltd's (ACIU) annual revenue growth rate based on the revenue reported in the past 5 years is : -24.46%

AC Immune Ltd's(ACIU) is not profitable as of its last reported annual financials.

The net profit margin for AC Immune Ltd's(ACIU) from its laster reported year is -186.44%

The return on equity (ROE) for AC Immune Ltd's(ACIU) from its last reported annual financials is : -37.31%

The return on assets (ROA) for AC Immune Ltd's(ACIU) from its last reported annual financials is : -15.83%

The return on invested capital (ROIC) for AC Immune Ltd's(ACIU) from its last reported annual financials is : -38.39%

The Debt to Equity ratio for AC Immune Ltd's(ACIU) from its last reported annual financials is : 0.00%

The dividend yield for AC Immune Ltd's(ACIU) from its laster reported year is 0.00%

AC Immune Ltd's(ACIU) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...